A leading Chinese blood cancer specialist has urged Hong Kong to deepen research collaboration with mainland China, saying the city could play a unique role in connecting the mainland’s growing scientific capabilities with the international life sciences community.
Zhu Chen, a professor at Ruijin Hospital of Shanghai Jiao Tong University’s school of medicine, received the 2026 Shaw Prize in Life Science and Medicine last week alongside French molecular biologist Anne Dejean and French doctor and…
Top Chinese cancer researcher calls on Hong Kong to deepen research ties with mainland

